Previous 10 | Next 10 |
NEW YORK, NY / ACCESSWIRE / May 29, 2019 / Kadmon Holdings, Inc. (NYSE: KDMN) today announced that Harlan W. Waksal, M.D., President and Chief Executive Officer, will present at the Jefferies 2019 Global Healthcare Conference in New York on Wednesday, June 5, 2019 at 11:30 a.m. ET. A live a...
This article is part of a series that provides an ongoing analysis of the changes made to Dan Loeb’s 13F stock portfolio on a quarterly basis. It is based on Third Point’s regulatory 13F Form filed on 05/15/2019. Please visit our Tracking Dan Loeb’s Third Point Portfoli...
Kadmon (NYSE: KDMN ): Q1 GAAP EPS of $0.02. More news on: Kadmon Holdings, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
NEW YORK, NY / ACCESSWIRE / May 9, 2019 / Kadmon Holdings, Inc. (NYSE: KDMN) today provided a business update and reported financial and operational results for the first quarter of 2019. ''The advancement of KD025 for the treatment of cGVHD continues to be Kadmon's key priority. We recentl...
The following slide deck was published by Kadmon Holdings, Inc. in conjunction with this Read more ...
NEW YORK, NY / ACCESSWIRE / April 3, 2019 / Kadmon Holdings, Inc. (NYSE: KDMN) today announced that Harlan W. Waksal, M.D., President and Chief Executive Officer, will present at the H.C. Wainwright Global Life Sciences Conference in London on Tuesday, April 9 at 12:10 p.m. BST (7:10 a.m. ET...
NEW YORK, NY / ACCESSWIRE / April 1, 2019 / Kadmon Holdings, Inc. (NYSE: KDMN) today announced that Arthur Kirsch has been nominated to stand for election to Kadmon's Board of Directors at the upcoming annual meeting of shareholders on May 15, 2019. Mr. Kirsch has more than 40 years of exper...
NEW YORK, NY / ACCESSWIRE / March 22, 2019 / Kadmon Holdings, Inc. (NYSE: KDMN) today announced that Susan Wiviott does not intend to stand for re-election to Kadmon's Board of Directors at the upcoming annual meeting of shareholders on May 15, 2019 (the "Annual Meeting"). On March 21, 2019,...
NEW YORK, NY / ACCESSWIRE / March 13, 2019 / Kadmon Holdings, Inc. (NYSE: KDMN) today announced that Harlan W. Waksal, M.D., President and Chief Executive Officer, will present at Oppenheimer's 29 th Annual Healthcare Conference in New York on Tuesday, March 19 at 2:10 p.m. ET. A live audi...
Kadmon (NYSE: KDMN ): Q4 GAAP EPS of -$0.37 misses by $0.25 . More news on: Kadmon Holdings, Earnings news and commentary, Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
- REZUROCK™ (belumosudil) 200 mg once daily (QD) tablets are now commercially available for shipment to prescribed patients in the United States - - Execution of strategic launch strategy underway; Third quarter REZUROCK net sales $12.2 million - - Sanofi acquisition of Kadm...
NEW YORK, NY / ACCESSWIRE / October 1, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced it will present data from the ongoing Phase 1 clinical trial of KD033, its anti-PD-L1/IL-15 fusion protein, in patients with metastatic or locally advanced solid tumors, in addition to other IL-...
FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Kadmon Holdings, Inc. Skyrockets Amid Entering Definitive Merger Agreement with Sanofi Kadmon Holdings, Inc. (NASDAQ: KDMN) surged 73% in premarket trading after entering...